FDA Clears Hologic’s Aptima SARS-CoV-2 Assay
Hologic, Inc. has received FDA 510(k) clearance for its Aptima SARS-CoV-2 assay, initially authorized for emergency use in 2020.
Read MorePosted by Chris Wolski | Feb 18, 2025 | Covid 19 |
Hologic, Inc. has received FDA 510(k) clearance for its Aptima SARS-CoV-2 assay, initially authorized for emergency use in 2020.
Read MorePosted by Chris Wolski | Feb 13, 2025 | Molecular Diagnostics |
Thermo Fisher Scientific has received FDA 510(k) clearance for its Applied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select Panel, a real-time PCR multiplex test.
Read MorePosted by Chris Wolski | Feb 7, 2025 | Disease States |
A study demonstrates safely reducing unnecessary pre-op tests can minimize waste and improve efficiency without compromising patient outcomes.
Read MorePosted by Chris Wolski | Jan 31, 2025 | Sequencing Systems |
Baylor Genetics has partnered with Epic’s Aura diagnostics suite, enabling ordering genetic tests and access results directly within the EHR.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Sequencing Systems |
Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read More